Identifying molecular residual disease (MRD) after treatment of localized lung cancer could
facilitate early intervention and personalization of adjuvant therapies. Here, we apply cancer …

There is currently great interest in applying neural networks to prediction tasks in medicine.
It is important for predictive models to be able to use survival data, where each patient has a …

Background Only around 20–30% of patients with non-small-cell lung cancer (NCSLC) have
durable benefit from immune-checkpoint inhibitors. Although tissue-based biomarkers (eg, …

Purpose To develop an intratumor partitioning framework for identifying high-risk subregions
from 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed …

PURPOSE: In proton therapy, uncertainty in the location of the distal dose edge can lead to
cautious treatment plans that reduce the dosimetric advantage of protons. After radiation …

Importance Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but
can cause toxic effects, including life-threatening damage to central structures. Retrospective …

Prognostic biomarkers that can reliably predict early disease progression of non-small cell
lung cancer (NSCLC) are needed for identifying those patients at high risk for progression, …

Background Oncologists use patients’ life expectancy to guide decisions and may benefit
from a tool that accurately predicts prognosis. Existing prognostic models generally use only a …

PURPOSE Knowing the treatments administered to patients with cancer is important for
treatment planning and correlating treatment patterns with outcomes for personalized medicine …

Objective Being able to predict a patient’s life expectancy can help doctors and patients
prioritize treatments and supportive care. For predicting life expectancy, physicians have been …